1 Market Overview

1.1 Nuclear Medicine & Radiopharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Diagnostic Radioisotopes

1.2.3 Therapeutic Radioisotopes

1.3 Market Analysis by Application

1.3.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Other

1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size & Forecast

1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Value (2016-2026))

1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume (2016-2026)

1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2026) & (USD/Unit)

1.5 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity Analysis

1.5.1 Global Nuclear Medicine & Radiopharmaceuticals Total Production Capacity (2016-2026)

1.5.2 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Nuclear Medicine & Radiopharmaceuticals Market Drivers

1.6.2 Nuclear Medicine & Radiopharmaceuticals Market Restraints

1.6.3 Nuclear Medicine & Radiopharmaceuticals Trends Analysis

2 Manufacturers Profiles

2.1 Bracco Imaging

2.1.1 Bracco Imaging Details

2.1.2 Bracco Imaging Major Business

2.1.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product and Services

2.1.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Bayer

2.2.1 Bayer Details

2.2.2 Bayer Major Business

2.2.3 Bayer Nuclear Medicine & Radiopharmaceuticals Product and Services

2.2.4 Bayer Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Mallinckrodt

2.3.1 Mallinckrodt Details

2.3.2 Mallinckrodt Major Business

2.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Product and Services

2.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Nordion

2.4.1 Nordion Details

2.4.2 Nordion Major Business

2.4.3 Nordion Nuclear Medicine & Radiopharmaceuticals Product and Services

2.4.4 Nordion Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Triad Isotopes

2.5.1 Triad Isotopes Details

2.5.2 Triad Isotopes Major Business

2.5.3 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Product and Services

2.5.4 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Lantheus

2.6.1 Lantheus Details

2.6.2 Lantheus Major Business

2.6.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Product and Services

2.6.4 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 IBA Group

2.7.1 IBA Group Details

2.7.2 IBA Group Major Business

2.7.3 IBA Group Nuclear Medicine & Radiopharmaceuticals Product and Services

2.7.4 IBA Group Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 GE Healthcare

2.8.1 GE Healthcare Details

2.8.2 GE Healthcare Major Business

2.8.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product and Services

2.8.4 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 China Isotope & Radiation

2.9.1 China Isotope & Radiation Details

2.9.2 China Isotope & Radiation Major Business

2.9.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services

2.9.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Jubilant Pharma

2.10.1 Jubilant Pharma Details

2.10.2 Jubilant Pharma Major Business

2.10.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product and Services

2.10.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Eli Lilly

2.11.1 Eli Lilly Details

2.11.2 Eli Lilly Major Business

2.11.3 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product and Services

2.11.4 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Advanced Accelerator Applications

2.12.1 Advanced Accelerator Applications Details

2.12.2 Advanced Accelerator Applications Major Business

2.12.3 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Product and Services

2.12.4 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 SIEMENS

2.13.1 SIEMENS Details

2.13.2 SIEMENS Major Business

2.13.3 SIEMENS Nuclear Medicine & Radiopharmaceuticals Product and Services

2.13.4 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Dongcheng

2.14.1 Dongcheng Details

2.14.2 Dongcheng Major Business

2.14.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services

2.14.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 Navidea

2.15.1 Navidea Details

2.15.2 Navidea Major Business

2.15.3 Navidea Nuclear Medicine & Radiopharmaceuticals Product and Services

2.15.4 Navidea Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturer

3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Nuclear Medicine & Radiopharmaceuticals

3.4 Market Concentration Rate

3.4.1 Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share

3.4.2 Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share

3.5 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Nuclear Medicine & Radiopharmaceuticals Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region

4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Region (2016-2026)

4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2026)

4.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)

4.3 Europe Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)

4.4 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)

4.5 South America Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)

4.6 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Type (2016-2026)

5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2016-2026)

5.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Application (2016-2026)

6.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2016-2026)

6.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)

7.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)

7.3 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country

7.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Country (2016-2026)

7.3.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)

8.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)

8.3 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country

8.3.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Country (2016-2026)

8.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)

9.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)

9.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Region

9.3.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)

10.2 South America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)

10.3 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country

10.3.1 South America Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Country (2016-2026)

10.3.2 South America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)

11.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)

11.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country

11.3.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Nuclear Medicine & Radiopharmaceuticals Typical Distributors

12.3 Nuclear Medicine & Radiopharmaceuticals Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type, (USD Million), 2021-2026

Table 2. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application, (USD Million), 2021-2026

Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors

Table 4. Bracco Imaging Major Business

Table 5. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 6. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Bayer Basic Information, Manufacturing Base and Competitors

Table 8. Bayer Major Business

Table 9. Bayer Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 10. Bayer Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors

Table 12. Mallinckrodt Major Business

Table 13. Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 14. Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Nordion Basic Information, Manufacturing Base and Competitors

Table 16. Nordion Major Business

Table 17. Nordion Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 18. Nordion Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Triad Isotopes Basic Information, Manufacturing Base and Competitors

Table 20. Triad Isotopes Major Business

Table 21. Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 22. Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Lantheus Basic Information, Manufacturing Base and Competitors

Table 24. Lantheus Major Business

Table 25. Lantheus Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 26. Lantheus Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. IBA Group Basic Information, Manufacturing Base and Competitors

Table 28. IBA Group Major Business

Table 29. IBA Group Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 30. IBA Group Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. GE Healthcare Basic Information, Manufacturing Base and Competitors

Table 32. GE Healthcare Major Business

Table 33. GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 34. GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors

Table 36. China Isotope & Radiation Major Business

Table 37. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 38. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Jubilant Pharma Basic Information, Manufacturing Base and Competitors

Table 40. Jubilant Pharma Major Business

Table 41. Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 42. Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors

Table 44. Eli Lilly Major Business

Table 45. Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 46. Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors

Table 48. Advanced Accelerator Applications Major Business

Table 49. Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 50. Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. SIEMENS Basic Information, Manufacturing Base and Competitors

Table 52. SIEMENS Major Business

Table 53. SIEMENS Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 54. SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Dongcheng Basic Information, Manufacturing Base and Competitors

Table 56. Dongcheng Major Business

Table 57. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 58. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Navidea Basic Information, Manufacturing Base and Competitors

Table 60. Navidea Major Business

Table 61. Navidea Nuclear Medicine & Radiopharmaceuticals Product and Services

Table 62. Navidea Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturer (2019-2021e) & (K Units)

Table 64. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 65. Market Position of Manufacturers in Nuclear Medicine & Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 66. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity by Company, (K Units): 2020 VS 2021

Table 67. Head Office and Nuclear Medicine & Radiopharmaceuticals Production Site of Key Manufacturer

Table 68. Nuclear Medicine & Radiopharmaceuticals New Entrant and Capacity Expansion Plans

Table 69. Nuclear Medicine & Radiopharmaceuticals Mergers & Acquisitions in the Past Five Years

Table 70. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2021e) & (K Units)

Table 71. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021-2026) & (K Units)

Table 72. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)

Table 73. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)

Table 74. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 75. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 76. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2016-2021e) & (USD Million)

Table 77. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2026) & (USD Million)

Table 78. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2021e) & (USD/Unit)

Table 79. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2026) & (USD/Unit)

Table 80. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 81. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 82. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2016-2021e) & (USD Million)

Table 83. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2026) & (USD Million)

Table 84. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2021e) & (USD/Unit)

Table 85. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2026) & (USD/Unit)

Table 86. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)

Table 87. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)

Table 88. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 89. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 90. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 91. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 92. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 93. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 94. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)

Table 95. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)

Table 96. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 97. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 98. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 99. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 100. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 101. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 102. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2021e) & (K Units)

Table 103. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021-2026) & (K Units)

Table 104. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)

Table 105. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)

Table 106. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 107. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 108. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 109. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 110. South America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)

Table 111. South America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)

Table 112. South America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 113. South America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 114. South America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 115. South America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 116. South America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 117. South America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 118. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)

Table 119. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)

Table 120. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)

Table 121. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)

Table 122. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)

Table 123. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)

Table 124. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)

Table 125. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)

Table 126. Direct Channel Pros & Cons

Table 127. Indirect Channel Pros & Cons

Table 128. Nuclear Medicine & Radiopharmaceuticals Typical Distributors

Table 129. Nuclear Medicine & Radiopharmaceuticals Typical Customers

List of Figures

Figure 1. Nuclear Medicine & Radiopharmaceuticals Picture

Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020

Figure 3. Diagnostic Radioisotopes

Figure 4. Therapeutic Radioisotopes

Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020

Figure 6. Oncology

Figure 7. Cardiology

Figure 8. Other

Figure 9. Global Nuclear Medicine & Radiopharmaceuticals Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 10. Global Nuclear Medicine & Radiopharmaceuticals Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Sales (2016-2026) & (K Units)

Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2026) & (USD/Unit)

Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity (2016-2026) & (K Units)

Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity by Geographic Region: 2020 VS 2021

Figure 15. Nuclear Medicine & Radiopharmaceuticals Market Drivers

Figure 16. Nuclear Medicine & Radiopharmaceuticals Market Restraints

Figure 17. Nuclear Medicine & Radiopharmaceuticals Market Trends

Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturer in 2020

Figure 19. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Manufacturer in 2020

Figure 20. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020

Figure 22. Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020

Figure 23. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 24. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2026)

Figure 25. North America Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 26. Europe Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 27. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 28. South America Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 29. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)

Figure 30. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 31. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2016-2026)

Figure 32. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2026) & (USD/Unit)

Figure 33. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 34. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2016-2026)

Figure 35. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2026) & (USD/Unit)

Figure 36. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 37. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 38. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 39. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 40. United States Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 44. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 45. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 46. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 47. Germany Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 53. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2026)

Figure 56. China Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Korea Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 63. South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 64. South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 65. South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)

Figure 69. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Egypt Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South Africa Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

Figure 77. Methodology

Figure 78. Research Process and Data Source